Theme A Session 7: HIV Vaccine and Immunopathogenesis 2
Tracks
.
| Wednesday, September 26, 2018 |
| 3:30 PM - 4:30 PM |
| Tuscan (Ground Floor) |
Details
Learning Objectives: This session will cover both advantages and weaknesses of the immune system in HIV. Presentations will explore immunological based prevention strategies that show promise for use in future vaccine strategies. In contrast, presentations will also cover HIV immunopathogenesis, where the immune system fails to control HIV.
Speaker
Professor Jintanat Ananworanich
Associate Director Of Hiv Therapeutics Research
US Military Hiv Research Program
Reservoir and Immune Markers in Tissue Compartments in Early Treated People from the RV254/SEARCH010 Study
3:30 PM - 3:50 PMBiography
Dr. Jintanat Ananworanich is Associate Director of Therapeutics Research at the U.S. Military HIV Research Program in Maryland, USA, and co-Director of the SEARCH unit at the Thai Red Cross AIDS Research Centre in Bangkok, Thailand. She is Professor of Internal Medicine at the University of Amsterdam and Professor of Pediatrics at the University of Maryland School of Medicine.
Professor Damian Purcell
Professor of Virology and Theme Leader for Viral Infectious Diseases
Uni Melbourne, Doherty Institute
A/Prof Amy Chung
Laboratory Head
Uni Melbourne, Doherty Institute
Chair
Sarah Fegan
John Zaunders
Senior Scientist
St Vincent's Hospital, Sydney
